Effect of bixalomer on coronary artery calcification in hemodialysis patients with hyperphosphatemia: a multi-center, randomized controlled trial

Effect of bixalomer on coronary artery calcification in hemodialysis patients with hyperphosphatemia: a multi-center, randomized controlled trial

Abstract Background Calcium carbonate is a first-line therapy for hyperphosphatemia in hemodialysis patients but is associated with progressive coronary and aortic calcification. Sevelamer compounds are alternatives to calcium-containing phosphate binders as they contain lower calcium levels. The se...

Full description

Bibliographic Details
Main Authors: Takashi Akiba, Keitaro Yokoyama, Hiroki Hase, Masahide Mizobuchi, Ryoichi Ando, Shuji Sakai, Kenji Fukushima, Tadao Akizawa
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Renal Replacement Therapy
Subjects:
Bixalomer
Coronary calcification
Hemodialysis
Randomized clinical trial
Online Access:http://link.springer.com/article/10.1186/s41100-019-0201-3

Internet

http://link.springer.com/article/10.1186/s41100-019-0201-3

Similar Items